2020
DOI: 10.1007/s10787-019-00680-8
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic potential of IKK-β inhibitors from natural phenolics for inflammation in cardiovascular diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
16
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 25 publications
(16 citation statements)
references
References 177 publications
0
16
0
Order By: Relevance
“…In the LIQ60 group, the cell viability was dramatically increased up to 92.06 ± 2.09% of normal control (100%). It was reported that LIQ increased cell viability via its anti-inflammatory [ 38 ], antioxidant, and antiapoptosis activity [ 20 , 23 ]. The current results further confirmed the safety of LIQ indicated in the previous publication [ 39 ].…”
Section: Resultsmentioning
confidence: 99%
“…In the LIQ60 group, the cell viability was dramatically increased up to 92.06 ± 2.09% of normal control (100%). It was reported that LIQ increased cell viability via its anti-inflammatory [ 38 ], antioxidant, and antiapoptosis activity [ 20 , 23 ]. The current results further confirmed the safety of LIQ indicated in the previous publication [ 39 ].…”
Section: Resultsmentioning
confidence: 99%
“…Previous studies have reported that FGF10 is a vital regulator of the NF-κB-dependent inflammatory response (22,23). IKBα is a major inhibitor of NF-κB and may remove NF-κB complexes in nuclei (36). NF-κB is comprised of p50 and p65 subunits and is activated by p65, which may promote the secretion of the inflammatory cytokines IL-1β, IL-6 and TNF-α (37,38).…”
Section: Discussionmentioning
confidence: 99%
“…Briefly, the IKK-β enzyme’s 3D structure (PDB ID: 4KIK) was downloaded from the RCSB Protein Data Bank ( ) with X-ray diffraction resolutions of 2.83 Å [ 38 , 39 ]. The obtained PDB file was prepared with the Protein Preparation Wizard of Schrodinger suite 2018 using OPLS3e force-field (Schrödinger Suite; Epik version 4.6; Impact version 8.1; Prime module, Schrödinger, LLC, New York, NY, USA, 2018).…”
Section: Methodsmentioning
confidence: 99%